GE Healthcare added another MRI technology to its imaging portfolio with the acquisition of Minneapolis-based Steady State Imaging.
SSI’s imaging platform is based on the University of Minnesota-developed SWIFT (Sweep Imaging with Fourier Transformation) method, which gives radiologists the ability to see tendons, ligaments and other tissues, an imaging capability not available in conventional imaging methods, according to GE Healthcare.
The General Electric Co. (NYSE:GE) health care unit said interest in the SWIFT method has increased among MRI researchers because of its potential for imaging around the lungs and other parts of the body where conventional magnetic resonance imaging is not typically effective.
SSI is a private company and the terms of the deal were not disclosed.
Here’s a roundup of companies announcing mergers, acquisitions and divestitures.
- Awarepoint acquires PCTS
Awarepoint Corp., a provider of real-time location systems (RTLS) for hospitals, acquired Patient Care Technology Systems (PCTS). The combined organization, which unites Awarepoint’s ZigBee-based technology platform with PCTS’s software platform and clinical applications, provides the industry’s enterprise-wide RTLS solution. PCTS currently serves 60 hospitals, while Awarepoint is installed at 93 hospitals and manages 150,627 assets, by far the most assets under management by a single company.
- CryoLife announces expiration of "go-shop" period related to its proposed Cardiogenesis takeover
CryoLife Inc. (NYSE:CRY), an implantable biological medical device and cardiovascular tissue processing company, today the expiration of the 20-day "go-shop" period that is part of its definitive agreement with Cardiogenesis Corp., whereby CryoLife is conducting a cash tender offer for 49.9 percent of its outstanding shares. The go-shop period was designed to give Cardiogenesis an opportunity to look for other buyout offers, but the company did not receive any proposals.
- LabCorp commences cash tender offer for Orchid
Laboratory Corp. of America Holdings (NYSE:LH) announced the commencement of its cash tender offer for all outstanding shares of the common stock of Orchid Cellmark Inc. (NSDQ:ORCH) for $2.80 per share. The tender offer is being made by OCM Acquisition Corp. a wholly owned subsidiary of LabCorp, pursuant to an Offer to Purchase, dated April 19. LabCorp and Orchid Cellmark previously announced that they entered into an Agreement and Plan of Merger, dated as of April 5, for LabCorp to acquire Orchid Cellmark.
- Terumo closes CaridianBCT acquisition
Terumo Corp. (Head Office: Shibuya-ku, Tokyo; President: Yutaro Shintaku) announced the completion of the previously announced pending acquisition of CaridianBCT Holding Corp. (Colorado). The acquisition of CaridianBCT is part of Terumo’s core strategy to achieve the long-term growth target revenue of ¥1 trillion ($12.1 billion) by the year 2020 and constitutes a new growth pillar for the company.